Eli Lilly & Co will invest $3 billion in China over the next decade to expand local production, with a focus on weight loss as the US drugmaker looks to cement its dominance in the booming obesity ...

SHANGHAI, March 11 (Reuters) - Eli Lilly (LLY.N), opens new tab plans to invest $3 billion in China over the next decade, which will help build production capacity for its experimental ‌type-2 ...

Orforglipron, Eli Lilly’s oral obesity drug, is under FDA review with a decision expected in April. The pharma has also filed for marketing authorization for the pill in China. Eli Lilly will pour $3 ...

CHONGQING, CHINA - JANUARY 29: In this photo illustration, a smartphone displays the logo of Eli Lilly and Company (NYSE: LLY), a U.S.-based pharmaceutical company specializing in prescription ...

Eli Lilly stock is down 13% from its 52-week high. Analysts still see some decent upside for the stock, with its average price target being north of $1,200. The company experienced tremendous growth ...

Eli Lilly stock is down 13% from its 52-week high. Analysts still see some decent upside for the stock, with its average price target being north of $1,200. The company experienced tremendous growth ...

Playing up being weird or out-of-place has long been part of Aubrey Plaza's acting repertoire, from one of her very first appearances on screen in Mystery Team and in her breakout role on Parks and ...

Forget the drug discovery hype. Here’s how the world’s largest pharma company is seeing a payoff from AI right now. There’s been huge hype around AI’s potential for drug discovery. But at Eli Lilly, ...

Maggie Gyllenhaal admitted she was worried about mixing business and her personal life before casting her husband Peter Sarsgaard in The Lost Daughter. Speaking to The New York Times’ "The Interview" ...

Novo Nordisk shares sank after the Danish drugmaker suffered a setback in its battle with Eli Lilly to dominate the market for weight-loss drugs.